Serum Antibody Igg Fda Approved?

DiscoveryProbe? FDA-approved Drug Library

L1021-0.05 50 uL/well(10 mM solution)
EUR 4514.4
Description: DiscoveryProbe? FDA-approved drug library includes 1496 FDA approved drugs for high throughput screening (HTS) and high content screening (HCS). It can be used to find new targets for old drugs. The bioactivity and safety of these drugs were confirmed by clinical trials.

Igg Serum Laboratories manufactures the serum antibody igg fda approved? reagents distributed by Genprice. The Serum Antibody Igg Fda Approved? reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact IgG Serum. Other Serum products are available in stock. Specificity: Serum Category: Antibody Group: Igg Fda

Fetal Bovine Serum (Mexico. USDA approved) - 50ml

50ml
EUR 38.12

Fetal Bovine Serum (Mexico. USDA approved) - 500ml

500ml
EUR 232.21

Fetal Bovine Serum (Chile. USDA approved) - 100ml

100ml
EUR 43.4

Fetal Bovine Serum (Chile. USDA approved) - 50ml

50ml
EUR 34.21

Fetal Bovine Serum (Chile. USDA approved) - 500ml

500ml
EUR 195.58

Fetal Bovine Serum (Central America. USDA approved) - 100ml

100ml
EUR 50.71

Fetal Bovine Serum (Central America. USDA approved) - 50ml

50ml
EUR 38.12

Igg Fda information

Fetal Bovine Serum (Mexico. USDA approved). Heat Inactivated - 500ml

FB-1360H/500 500ml
EUR 235.29

Fetal Bovine Serum (Central America. USDA approved). Heat Inactivated - 100ml

FB-1345H/100 100ml
EUR 53.79

Fetal Bovine Serum (Central America. USDA approved). Heat Inactivated - 500ml

FB-1345H/500 500ml
EUR 235.29

FBS - Heat Inactivated Premium Imported Fetal Bovine Serum (USDA Approved)

FBS002-HI each
EUR 302.4

FBS - Heat Inactivated Qualified Imported Fetal Bovine Serum (USDA Approved)

FBS006-HI each
EUR 279

FBS-Heat Inactivated Premium Imported Fetal Bovine Serum (USDA Approved)

MBS555989-500mL 500mL
EUR 485

FBS-Heat Inactivated Premium Imported Fetal Bovine Serum (USDA Approved)

MBS555989-5x500mL 5x500mL
EUR 2040

FBS-Heat Inactivated Standard Imported Fetal Bovine Serum (USDA Approved)

MBS555993-500mL 500mL
EUR 425

FBS-Heat Inactivated Standard Imported Fetal Bovine Serum (USDA Approved)

MBS555993-5x500mL 5x500mL
EUR 1760

FBS-Heat Inactivated Qualified Imported Fetal Bovine Serum (USDA Approved)

MBS555998-500mL 500mL
EUR 385

FBS-Heat Inactivated Qualified Imported Fetal Bovine Serum (USDA Approved)

MBS555998-5x500mL 5x500mL
EUR 1590

SARS-CoV-2 Human IgG (4-Plex) Multiplex ELISA Kit (EUA Approved)

MEK2009-1 1 kit
EUR 1122
Description:

Product Overview

_x000D_

The Q-Plex™ SARS-CoV-2 Human IgG (4-plex) Multiplex ELISA Kit is a qualitative chemiluminescent assay (ELISA) allowing concurrent measurement of human IgG antibodies to SARS-CoV-2 S1 and SARS-CoV-2 S2 proteins in serum and plasma samples. It has been authorized by FDA under a EUA for use by high complexity CLIA labs. Sensitive, reproducible, and convenient 96-well format requiring low sample volumes. Requires the Q-View™ Imaging System for analysis.

_x000D__x000D_

Assay Principle

_x000D_

The Q-Plex™ SARS-CoV-2 Human IgG (4-Plex) multiplex assay is a qualitative enzyme-linked immunosorbent assay that detects IgG antibodies to SARS-CoV-2 in human serum or plasma. SARS-CoV-2 is the novel coronavirus that causes COVID-19. The SARS-CoV-2 virus has several structural proteins including two spike proteins, S1 and S2. When an individual is infected with the SARS-CoV-2 virus, their immune system produces antibodies to these viral proteins. The typical immune response produces detectable antibody levels ~8-10 days following the onset of symptoms.

_x000D__x000D_

The Q-Plex SARS-CoV-2 Human IgG Quantitative (4-Plex) Multiplex ELISA detects IgG antibodies to both the S1 and S2 spike proteins present in a blood sample. If antibodies are detected, the result will be considered positive. If antibodies are not detected, the result will be considered negative. The assay only detects IgG antibodies, not other classes of antibodies such as IgM or IgA.

_x000D__x000D_

The multiplex assay allows for simultaneous indirect ELISA on the following four printed spots:;_x000D_

    _x000D_
  1. SARS-CoV-2 Spike Glycoprotein (S1), a recombinant antigen which contains amino acids 1-674 of subunit 1. Spike S1 is expressed in mammalian HEK293 cells with a Sheep Fc-Tag.
  2. _x000D_
  3. SARS-CoV-2 Spike Glycoprotein (S2) is a recombinant antigen which contains the Spike subunit 2 protein, amino acids 685-1211. Spike S2 is expressed in mammalian HEK293 cells with a Sheep Fc-Tag.
  4. _x000D_
  5. Sheep Fc is a negative control to ensure no cross-reactivity occurs between human IgGs in the sample and the Fc-Tag on the SARS-Cov-2 Spike proteins.
  6. _x000D_
  7. Anti-Human IgG is a positive control to ensure the kit performs and the IFU was followed correctly.
  8. _x000D_

_x000D__x000D__x000D_

Assay Validation

_x000D_

The Q-Plex™ SARS-CoV-2 Human IgG (4-Plex) ELISA tests for IgG antibodies to either the SARS-CoV-2 S1 protein or the SARS-CoV-2 S2 protein. Our validation studies identified measurable improvement in clinical performance when results from the S1 and S2 assays are considered together rather than single assays (see assay validation data below). Quansys recommends that a sample should only be considered positive for the presence of SARS-CoV-2 reactive IgGs when antibodies reactive to both S1 and S2 are detected.

_x000D_

Negative samples, collected prior to August 2019, and known positive samples collected from individuals who tested positive for COVID-19 on a molecular test at least 14 days prior to sample collection were used to determine clinical sensitivity and specificity.

_x000D_

Evaluating the S1 and S2 simultaneously allows for greater clinical sensitivity and specificity.

_x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_
SARS-CoV-2 IgG Assay (Combined Result from S1 & S2) vs. Molecular COVID-19 Test
N = 576Confirmed PositiveConfirmed Negative
IgG Test Positive330
IgG Test Negative1542
_x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_
The combined S1 & S2 reactive antibody assay demonstrates:
Estimated Sensitivity (PPA)97%
Estimated Specificity (NPA)100%
PPV100%
NPV100%
_x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_
SARS-CoV-2 IgG Assay Characteristics
PrincipleIndirect ELISA
Sample TypeHuman Serum, Plasma, Whole Blood
Sample Volume2 µL
Assay Incubation2 hours, RT
Total Wash Steps3
Within Plate Reproducibility8% CV
Between Plate Reproducibility10% CV
_x000D__x000D_

Kit Components

_x000D_

Each kit contains a 96-well plate, featuring the relevant biomarker panel in each well, and all reagents required to perform testing.

_x000D_

Reagents include:

_x000D_

Wash Buffer Concentrate (20X): Liquid, 50 mL/vial of a concentrated solution of buffered surfactant;_x000D_Sample Diluent (2X): Liquid, 10 mL/vial of a concentrated buffered protein solution with preservatives;_x000D_Detection Mix: Liquid, 6 mL/vial of biotinylated antibodies in a buffered protein solution with preservatives;_x000D_Calibrators (High, Low, Negative): Lyophilized, human serum diluted in a buffered protein base;_x000D_Streptavidin-HRP (1X): Liquid, 6 mL/vial of streptavidin-conjugated horseradish peroxidase;_x000D_Substrate A: Liquid, 3 mL/vial of peroxide solution;_x000D_Substrate B+: Liquid, 3 mL/vial of luminol solution;_x000D_Plate Seals (3): Adhesive strips

_x000D__x000D_

Kit Processing

_x000D_

The Multiplex assays require the use of the Q-View™ software to read and interpret the test results. A fully-functional, free trial version of the software is available to download, install, and use to analyze your first kit (s). At the end of the trial period, a purchased license is required to continue the use of the Q-View software.

_x000D_

Q-Plex arrays are developed and optimized to work with Q-View imagers. We do not guarantee the results obtained from other imagers because not all imagers are compatible with Q-Plex arrays.

DiscoveryProbe? FDA-approved Drug Library

L1021-0.05 50 uL/well(10 mM solution)
EUR 4514.4
Description: DiscoveryProbe? FDA-approved drug library includes 1496 FDA approved drugs for high throughput screening (HTS) and high content screening (HCS). It can be used to find new targets for old drugs. The bioactivity and safety of these drugs were confirmed by clinical trials.

DiscoveryProbe? FDA-approved Drug Library

L1021-5 5 mg/well
EUR 15789.6
Description: DiscoveryProbe? FDA-approved drug library includes 1496 FDA approved drugs for high throughput screening (HTS) and high content screening (HCS). It can be used to find new targets for old drugs. The bioactivity and safety of these drugs were confirmed by clinical trials.

DiscoveryProbe™ FDA-approved Drug Library

L1021-.02 20uL/well(10 mM solution),96 Well Microplates
EUR 1488
Description: 2320 FDA-approved drugs

DiscoveryProbe™ FDA-approved Drug Library

L1021-.1 100 uL/well(10 mM solution)
EUR 4392
Description: 2320 FDA-approved drugs

DiscoveryProbe™ FDA-approved Drug Library

L1021-.1-1 100uL/well(10 mM solution),96 Well Racks With Screw Cap
EUR 5496
Description: 2320 FDA-approved drugs